Diagnosis and management of upper extremity deep-vein thrombosis in adults

Summary

Upper extremity deep-vein thrombosis (UEDVT) is common and can cause important complications, including pulmonary embolism and post-thrombotic syndrome. An increase in the use of central venous catheters, particularly peripherally inserted central catheters has been associated with an increasing rate of disease. Accurate diagnosis is essential to guide management, but there are limitations to the available evidence for available diagnostic tests. Anticoagulation is the mainstay of therapy, but interventional treatments may be considered in select situations. The risk of UEDVT may be reduced by more careful selection of patients who receive central venous catheters and by use of smaller catheters. Herein we review the diagnosis, management and prevention of UEDVT. Due to paucity of research, some principles are drawn from studies of lower extremity DVT. We present a practical approach to diagnosing the patient with suspected deep-vein thrombosis of the upper extremity.

Keywords

Venous thrombosis - diagnosis management - deep-vein thrombosis - magnetic resonance - risk factors

• References

• 1 Kearon C. et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl. 06) 454S-545S.
• 2 Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med 2011; 364: 861-869.
• 3 Linnemann B. et al. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry. Thromb Haemost 2008; 100: 440-446.
• 4 Joffe HV, Goldhaber SZ. Upper-extremity deep vein thrombosis. Circulation 2002; 106: 1874-1880.
• 5 Hingorani A. et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg 1997; 26: 853-860.
• 6 Owens CA. et al. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol 2010; 21: 779-787.
• 7 Spencer FA. et al. Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 2007; 120: 678-684.
• 8 Joffe HV. et al. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110: 1605-1611.
• 9 Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist 2004; 9: 207-216.
• 10 Luciani A. et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology 2001; 220: 655-660.
• 11 Martin C. et al. Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med 1999; 27: 2626-2629.
• 12 De Cicco M. et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 1997; 86: 101-113.
• 13 Bonfils P. et al. Prospective study of thromboses of the subclavian vein after setting implantable venous access systems in cervico-facial cancerology. Ann Oto-laryngol Chir Cervicofac 1996; 113: 425-429.
• 14 Bern MM. et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 423-428.
• 15 Mismetti P. et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 2003; 88: 67-73.
• 16 Couban S. et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005; 23: 4063-4069.
• 17 Verso M. et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057-4062.
• 18 Karthaus M. et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 2006; 17: 289-296.
• 19 Niers TM. et al. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. J Thromb Haemost 2007; 5: 1878-1882.
• 20 Cortelezzi A. et al. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol 2005; 129: 811-817.
• 21 Lee AY. et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006; 24: 1404-1408.
• 22 Young AM. et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009; 373: 567-574.
• 23 Evans RS. et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest 2010; 138: 803-810.
• 24 van Rooden CJ. et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005; 23: 2655-2660.
• 25 Saber W. et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost 2011; 9: 312-319.
• 26 Korkeila P. et al. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: A prospective serial venographic study. Ann Med 2008; 31: 1-8.
• 27 Isma N. et al. Upper extremity deep venous thrombosis in the population-based Malmo thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality. Thromb Res 2010; 125: 335e-338.
• 28 Anderson AJ. et al. Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 1989; 95: 71-75.
• 29 Girolami A. et al. Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs. Blood Coagul Fibrinolysis 1999; 10: 455-457.
• 30 Ellis MH. et al. Risk factors and management of patients with upper limb deep vein thrombosis. Chest 2000; 117: 43-46.
• 31 Kearon C. et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) Suppl e419S-494S.
• 32 Chan WS, Ginsberg JS. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the ’ART’ behind the clot. J Thromb Haemost 2006; 4: 1673-1677.
• 33 Martinelli I. et al. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 2004; 110: 566-570.
• 34 Hingorani A. et al. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. J Vasc Surg 2005; 41: 476-478.
• 35 Prandoni P. et al. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. Br Med J 2004; 329: 484-485.
• 36 Horattas MC. et al. Changing concepts of deep venous thrombosis of the upper extremity--report of a series and review of the literature. Surgery 1988; 104: 561-567.
• 37 Kooij JD. et al. Pulmonary embolism in deep venous thrombosis of the upper extremity: more often in catheter-related thrombosis. Netherl J Med 1997; 50: 238-242.
• 38 Kerr TM. et al. Upper extremity venous thrombosis diagnosed by duplex scanning. Am J Surg 1990; 160: 202-206.
• 39 Munoz FJ. et al. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008; 133: 143-148.
• 40 Lechner D. et al. Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost 2008; 6: 1269-1274.
• 41 Prandoni P. et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 1997; 157: 57-62.
• 42 Elman EE, Kahn SR. The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res 2006; 117: 609-614.
• 43 Kahn SR. et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e195S-226S.
• 44 Wagman LD. et al. Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2008; 6: 716-753.
• 45 Evans RS. et al. Reduction of Peripherally Inserted Central Catheter Associated Deep Venous Thrombosis. Chest. 2012 epub ahead of print.
• 46 Krafte-Jacobs B. et al. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Ped 1995; 126: 50-54.
• 47 Pierce CM. et al. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Inten Care Med 2000; 26: 967-972.
• 48 Anton N. et al. Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 2009; 123: e453-458.
• 49 Akl EA. et al. Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis. Cancer 2008; 112: 2483-2492.
• 50 Streiff MB. The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients. Thromb Res 2010; 125 (Suppl. 02) 128-133.
• 51 Urschel Jr. HC, Razzuk MA. Paget-Schroetter syndrome: what is the best management?. Ann Thorac Surg 2000; 69: 1663-1669.
• 52 Sanders RJ. et al. Diagnosis of thoracic outlet syndrome. J Vasc Surg 2007; 46: 601-604.
• 53 Constans J. et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008; 99: 202-207.
• 54 Knudson GJ. et al. Color Doppler sonographic imaging in the assessment of upper-extremity deep venous thrombosis. Am J Roentgenol 1990; 154: 399-403.
• 55 Merminod T. et al. Limited usefulness of D-dimer in suspected deep vein thrombosis of the upper extremities. Blood Coagul Fibrinolysis 2006; 17: 225-226.
• 56 Baarslag HJ. et al. Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med 2002; 136: 865-872.
• 57 Patel MC. et al. Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion. Radiology 1999; 211: 579-583.
• 58 Di Nisio M. et al. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost 2010; 8: 684-692.
• 59 Bates SM. et al. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e351S-418S.
• 60 Hull R. et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation 1981; 64: 622-625.
• 61 Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-144.
• 62 Baarslag HJ. et al. Deep vein thrombosis of the upper extremity: intra- and interobserver study of digital subtraction venography. Eur Radiol 2003; 13: 251-255.
• 63 Leizorovicz A. et al. The assessment of deep vein thromboses for therapeutic trials. Angiology 2003; 54: 19-24.
• 64 Heye S. et al. Upper-extremity venography: CO2 versus iodinated contrast material. Radiology 2006; 241: 291-297.
• 65 Thomas SM. et al. Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysis. Clin Radiol 2008; 63: 299-304.
• 66 Kim H. et al. Role of CT venography in the diagnosis and treatment of benign thoracic central venous obstruction. Korean J Radiol 2003; 4: 146-152.
• 67 Sampson FC. et al. The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur Radiol 2007; 17: 175-181.
• 68 Stein PD. et al. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 2010; 152: 434-443 W142-3.
• 69 Oxtoby JW. et al. 3D gadolinium-enhanced MRI venography: evaluation of central chest veins and impact on patient management. Clin Radiol 2001; 56: 887-894.
• 70 Tanju S. et al. Direct contrast-enhanced 3D MR venography evaluation of upper extremity deep venous system. Diagn Interv Radiol 2006; 12: 74-79.
• 71 Thornton MJ. et al. A three-dimensional gadolinium-enhanced MR venography technique for imaging central veins. AJR Am J Roentgenol 1999; 173: 999-1003.
• 72 Baarslag HJ. et al. Magnetic resonance venography in consecutive patients with suspected deep vein thrombosis of the upper extremity: initial experience. Acta Radiol 2004; 45: 38-43.
• 73 Baarslag HJ. et al. Diagnosis and management of deep vein thrombosis of the upper extremity: a review. Eur Radiol 2004; 14: 1263-1274.
• 74 Rose SC. et al. MR angiography for mapping potential central venous access sites in patients with advanced venous occlusive disease. Am J Roentgenol 1996; 166: 1181-1187.
• 75 Hartnell GG. et al. Magnetic resonance angiography of the central chest veins. A new gold standard?. Chest 1995; 107: 1053-1057.
• 76 Fraser DG. et al. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002; 136: 89-98.
• 77 Kearon C. A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism. J Thromb Haemost 2012; 10: 507-511.
• 78 Sajid MS. et al. Upper limb deep vein thrombosis: a literature review to streamline the protocol for management. Acta Haematol 2007; 118: 10-18.
• 79 Laerum F, Holm HA. Postphlebographic thrombosis: a double-blind study with methylglucamine metrizoate and metrizamide. Radiology 1981; 140: 651-654.
• 80 Heijboer H. et al. Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis. Acta Radiologica 1992; 33: 297-300.
• 81 Cronan JJ, Leen V. Recurrent deep venous thrombosis: limitations of US. Radiology 1989; 170: 739-742.
• 82 Linkins LA. et al. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res 2006; 117: 241-247.
• 83 Baglin T. et al. Duration of anticoagulant therapy after a first episode of unprovoked pulmonary embolus or deep vein thrombosis: guidance from the scientific and standardization committee of the international society on thrombosis and haemostasis. J Thromb Haemost 2012; 10: 698-702.
• 84 Goldhaber SZ. et al. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76: 393-397.
• 85 Vedantham S. Interventions for Deep Vein Thrombosis: Reemergence of a Promising Therapy. Am J Med 2008; 121: S28-S39.
• 86 Vedantham S. et al. Society of Interventional Radiology position statement: treatment of acute iliofemoral deep vein thrombosis with use of adjunctive catheter-directed intrathrombus thrombolysis. J Vasc Interv Radiol 2006; 17: 613-616.
• 87 Murphy EH. et al. Endovascular intervention for lower extremity deep venous thrombosis. In: Peripheral Endovascular Interventions. 3rd ed. Springer; New York: 2010: pp203-213.
• 88 Sharafuddin MJ. et al. Endovascular management of venous thrombotic diseases of the upper torso and extremities. J Vasc Interv Radiol 2002; 13: 975-990.
• 89 Maleux G. et al. Catheter-directed thrombolytic therapy for thoracic deep vein thrombosis is safe and effective in selected patients with and without cancer. Eur Radiol 2010; 20: 2293-2300.
• 90 Enden T. et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 2009; 7: 1268-1275.
• 91 Wicky ST. Acute deep vein thrombosis and thrombolysis. Tech Vasc Interv Radiol 2009; 12: 148-153.
• 92 Comerota AJ. Randomized trial evidence supporting a strategy of thrombus removal for acute DVT. Semin Vasc Surg 2010; 23: 192-198.
• 93 Sheynzon V. et al. Power pulse spray pharmacomechanical thrombectomy for the treatment of upper extremity deep vein thrombosis. J Vasc Interv Radiol. 2008 Supplement: S132
• 94 Urschel Jr. HC, Patel AN. Paget-Schroetter syndrome therapy: failure of intravenous stents. Ann Thorac Surg 2003; 75: 1693-1696.
• 95 Oderich GS. et al. Stent placement for treatment of central and peripheral venous obstruction: a long-term multi-institutional experience. J Vasc Surg 2000; 32: 760-769.
• 96 Schneider DB. et al. Combination treatment of venous thoracic outlet syndrome: open surgical decompression and intraoperative angioplasty. J Vasc Surg 2004; 40: 599-603.
• 97 Sadaf A. et al. Significant caval penetration by the celect inferior vena cava filter: attributable to filter design?. J Vasc Interv Radiol 2007; 18: 1447-1450.
• 98 Adams JT, DeWeese JA. “Effort”thrombosis of the axillary and subclavian veins. J Trauma 1971; 11: 923-930.
• 99 Kovacs MJ. et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007; 5: 1650-1653.